Drug shows promise as immune therapy for cancer

by Ziba Kashef,Yale UniversityNew Yale-led research may offer novel immunotherapies for skin, colon, breast, pancreatic and other cancers. Credit: stock.adobe.comA therapy developed by Yale rese

Updated on: May 25,2024

Drug shows promise as immune therapy for cancer

by Ziba Kashef,Yale UniversityNew Yale-led research may offer novel immunotherapies for skin, colon, breast, pancreatic and other cancers. Credit: stock.adobe.comA therapy developed by Yale rese

Updated on:May 25,2024

Radiation therapy for patients with breast cancer explained

by Mayo Clinic News NetworkCredit: Unsplash/CC0 Public DomainRadiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy kill cancer cells

Updated on: November 08,2024

Radiation therapy for patients with breast cancer explained

by Mayo Clinic News NetworkCredit: Unsplash/CC0 Public DomainRadiation therapy is a common component of breast cancer treatment for patients. The high-powered beams of intense energy kill cancer cells

Updated on:November 08,2024

Examining resistance to immunotherapy in ovarian cancer

byMemorial Sloan Kettering Cancer CenterTME of HGSOC at single-cell resolution.a, Overview of the MSK SPECTRUM cohort and specimen collection workflow.b, UMAP plot of cells profiled

Updated on: December 28,2023

Examining resistance to immunotherapy in ovarian cancer

byMemorial Sloan Kettering Cancer CenterTME of HGSOC at single-cell resolution.a, Overview of the MSK SPECTRUM cohort and specimen collection workflow.b, UMAP plot of cells profiled

Updated on:December 28,2023

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Updated on: February 20,2024

Researchers turn cancer cells into less harmful cell types

by University of BaselHigh-throughput drug screen reveals estrogen receptor α (ERα) induction in triple-negative breast cancer (TNBC) upon polo-like kinase 1 (PLK1) inhibition. A Schematic of the

Updated on:February 20,2024

Newly discovered mechanism helps tumor cells evade the immune system early on

byTechnical University MunichDr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar (left) and doctoral student Sebastian Lache

Updated on: April 28,2024

Newly discovered mechanism helps tumor cells evade the immune system early on

byTechnical University MunichDr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar (left) and doctoral student Sebastian Lache

Updated on:April 28,2024

Research uncovers potential pathway for breast cancer treatment

by Elizabeth Chapin,University of KentuckyYadi Wu, Ph.D., University of Kentucky Markey Cancer Center. Credit: Ben Corwin/University of KentuckyA recent University of Kentucky Markey Cancer Cent

Updated on: March 20,2024

Research uncovers potential pathway for breast cancer treatment

by Elizabeth Chapin,University of KentuckyYadi Wu, Ph.D., University of Kentucky Markey Cancer Center. Credit: Ben Corwin/University of KentuckyA recent University of Kentucky Markey Cancer Cent

Updated on:March 20,2024

Neutrons reveal how a common tropical plant preys on cancer, preserves healthy cells

by Oak Ridge National LaboratoryFrom left are UWindsor students Isabelle Dib, Dominik Dziura, Stuart Castillo and Maksymilian Dziura at ORNL’s Neutron Spin Echo spectrometer. Their work advances

Updated on: February 23,2024

Neutrons reveal how a common tropical plant preys on cancer, preserves healthy cells

by Oak Ridge National LaboratoryFrom left are UWindsor students Isabelle Dib, Dominik Dziura, Stuart Castillo and Maksymilian Dziura at ORNL’s Neutron Spin Echo spectrometer. Their work advances

Updated on:February 23,2024

Thalidomide reveals path for targeting undruggable transcription factors for cancer treatment

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsThalidomide, a morning-sickness drug recalled in the 1960s because it caused devastating birth de

Updated on: March 06,2024

Thalidomide reveals path for targeting undruggable transcription factors for cancer treatment

by Tom Ulrich,Broad Institute of MIT and HarvardCredit: Susanna M. Hamilton, Broad CommunicationsThalidomide, a morning-sickness drug recalled in the 1960s because it caused devastating birth de

Updated on:March 06,2024

Researchers identify subtypes of squamous cell lung cancer

by H. Lee Moffitt Cancer Center & Research InstituteCredit: CC0 Public DomainLung cancer is the number one cause of cancer-related deaths in the United States, with squamous cell lung cancer

Updated on: June 06,2024

Researchers identify subtypes of squamous cell lung cancer

by H. Lee Moffitt Cancer Center & Research InstituteCredit: CC0 Public DomainLung cancer is the number one cause of cancer-related deaths in the United States, with squamous cell lung cancer

Updated on:June 06,2024

Bioengineers combine lab-on-a-chip technology with AI to improve cancer immunotherapy

byIndiana UniversityTheplatform tracks T cell infiltration of tumor spheroids, which are 3D structures made of cancer cells. Credit: Feng GuoAn interdisciplinary team of researchers led by

Updated on: January 04,2024

Bioengineers combine lab-on-a-chip technology with AI to improve cancer immunotherapy

byIndiana UniversityTheplatform tracks T cell infiltration of tumor spheroids, which are 3D structures made of cancer cells. Credit: Feng GuoAn interdisciplinary team of researchers led by

Updated on:January 04,2024

Cancer incidence alarming among young people in Middle East, researcher finds

by University of SharjahCredit: Unsplash/CC0 Public DomainCancer cases are unusually high among middle aged people in the Middle East contrary to western countries where they usually hit people a

Updated on: February 03,2024

Cancer incidence alarming among young people in Middle East, researcher finds

by University of SharjahCredit: Unsplash/CC0 Public DomainCancer cases are unusually high among middle aged people in the Middle East contrary to western countries where they usually hit people a

Updated on:February 03,2024

Some cervical cancer screening strategies more cost-effective

(HealthDay)—A cervical cancer screening strategy that involves cytologic testing every three years from ages 21 to 29 years and then continuing cytologic testing or switching to low-cost high-risk hum

Updated on: May 21,2024

Some cervical cancer screening strategies more cost-effective

(HealthDay)—A cervical cancer screening strategy that involves cytologic testing every three years from ages 21 to 29 years and then continuing cytologic testing or switching to low-cost high-risk hum

Updated on:May 21,2024